Atlas Trials

Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis

Clinical trial NCT04801433 · COMPLETED

Trial details

NCT number
NCT04801433
Sponsor
Xijing Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Scalp Psoriasis
Start date
2018-11-30
Primary completion
2019-07-04
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.